MBOAT7 and fatty liver disease: The most straightforward explanation is that either the substrates (LPIs or fatty acyl-CoAs) or products (38:3, 38:4, and 38:5 PI) of the MBOAT7 reaction initiate some signal in the liver to promote hepatic steatosis, inflammation, and fibrosis.